Pharmacovigilance study of INSTIs associated with weight gain and glucose/lipid metabolism adverse events based on the FDA adverse event reporting system

药物警戒 不利影响 医学 不良事件报告系统 事件(粒子物理) 体重增加 重症监护医学 药物不良事件 药理学 内科学 梅德林 急诊医学 风险评估 安全概况 药物代谢 生物信息学 事件数据
作者
Leidan Zhang,Ling Chen,Jia Tang,Xiaosheng Liu,liyuan Zheng,Fada Wang,Xin Huang,Wei Cao,Taisheng Li
出处
期刊:Hiv Medicine [Wiley]
卷期号:27 (5): 749-760 被引量:3
标识
DOI:10.1111/hiv.70205
摘要

OBJECTIVE: Integrase strand transfer inhibitors (INSTIs) are widely used in antiretroviral therapy (ART) for people with HIV due to their efficacy and tolerability. However, concerns about weight gain and metabolic disturbances have emerged. This study aimed to evaluate the association between INSTIs and metabolic adverse events (AEs), including weight gain and glucose/lipid disorders. DESIGN: The US Food and Drug Administration Adverse Event Reporting System (FAERS) reports from the first quarter (Q1) of 2004 through Q1 2025 were analysed for AEs associated with bictegravir (BIC), dolutegravir (DTG), elvitegravir (EVG) and raltegravir (RAL), focusing on weight gain and glucose/lipid metabolism disorders. Kaplan-Meier curves and Weibull shape parameter tests were used to analyse the cumulative incidence and time to onset of AEs. RESULTS: All four INSTIs were associated with safety signals for weight gain and glucose/lipid metabolism disorders. BIC had the highest reporting odds ratio (ROR) for weight gain (ROR: 7.70, 95% CI: 7.00-8.47), while DTG had the highest for glucose/lipid disorders (1.81, 95% CI: 1.66-1.97). Younger age and female sex were linked to BIC-related weight gain; older age was a risk factor for DTG-, EVG- and RAL-related glucose/lipid AEs. DTG-associated events occurred earlier than those with other agents. CONCLUSION: This study identified metabolic AEs associated with INSTIs, with agent-specific differences in risk and timing, highlighting the need for regular monitoring and individualized management during INSTI-based ART.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
Owen的应助被科研通管家采纳,获得10
刚刚
桐桐的应助被科研通管家采纳,获得10
刚刚
123完成签到,获得积分20
刚刚
儒雅绿草完成签到,获得积分10
1秒前
Johnny完成签到,获得积分10
1秒前
辛勤电源发布了新的文献求助10
1秒前
斯文败类的应助被溜溜吧采纳,获得10
2秒前
leahlin完成签到,获得积分10
2秒前
yxb发布了新的文献求助10
2秒前
2秒前
东巷那只鼠完成签到,获得积分10
3秒前
3秒前
3秒前
正直若颜完成签到,获得积分10
3秒前
Zongxin发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
寂寞的小鱼的应助被Moon采纳,获得10
4秒前
keikei完成签到,获得积分10
4秒前
xu完成签到,获得积分10
4秒前
笨考拉完成签到,获得积分10
4秒前
朴实鹏煊完成签到 ,获得积分10
5秒前
秋风的应助被晚晚采纳,获得10
5秒前
czt发布了新的文献求助10
5秒前
乐乐的应助被ddddd采纳,获得10
5秒前
6秒前
大大咧咧发布了新的文献求助10
7秒前
腼腆的寒风完成签到 ,获得积分10
9秒前
Lily发布了新的文献求助10
9秒前
10秒前
shark发布了新的文献求助10
10秒前
10秒前
慕青的应助被277采纳,获得10
10秒前
ww发布了新的文献求助10
11秒前
上官天宇发布了新的文献求助10
11秒前
11秒前
yxb完成签到 ,获得积分20
12秒前
wanci的应助被钟梓袄采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148